Trial Profile
An open-label, cross-over, first-in-human study to evaluate the food effect of single-dose of Cenerimod in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Nov 2016
Price :
$35
*
At a glance
- Drugs Cenerimod (Primary)
- Indications Systemic lupus erythematosus
- Focus First in man; Pharmacokinetics; Therapeutic Use
- 15 Nov 2016 New trial record